Oliver Schacht - OpGen Executive Development
| OPGNDelisted Stock | USD 1.90 0.15 7.32% |
Executive
Oliver Schacht is Executive Development of OpGen Inc
| Age | 53 |
| Phone | 240 813 1260 |
| Web | https://www.opgen.com |
Oliver Schacht Latest Insider Activity
Tracking and analyzing the buying and selling activities of Oliver Schacht against OpGen pink sheet is an integral part of due diligence when investing in OpGen. Oliver Schacht insider activity provides valuable insight into whether OpGen is net buyers or sellers over its current business cycle. Note, OpGen insiders must abide by specific rules, including filing SEC forms every time they buy or sell OpGen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Oliver Schacht over a year ago Exercise or conversion by Oliver Schacht of 12469 shares of OpGen subject to Rule 16b-3 | ||
Oliver Schacht over a year ago Exercise or conversion by Oliver Schacht of 1875 shares of OpGen subject to Rule 16b-3 |
OpGen Management Efficiency
The company has return on total asset (ROA) of (0.5224) % which means that it has lost $0.5224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.1492) %, meaning that it created substantial loss on money invested by shareholders. OpGen's management efficiency ratios could be used to measure how well OpGen manages its routine affairs as well as how well it operates its assets and liabilities.OpGen Inc currently holds 13.04 M in liabilities with Debt to Equity (D/E) ratio of 1.11, which is about average as compared to similar companies. OpGen Inc has a current ratio of 1.1, suggesting that it may not be capable to disburse its financial obligations when due. Debt can assist OpGen until it has trouble settling it off, either with new capital or with free cash flow. So, OpGen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OpGen Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OpGen to invest in growth at high rates of return. When we think about OpGen's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| John Ballard | Vivos Therapeutics | N/A | |
| Tom Huang | Sight Sciences | N/A | |
| Indranil Dey | Bluejay Diagnostics | 61 | |
| Reay MD | Sight Sciences | N/A | |
| Marc MD | enVVeno Medical Corp | 75 | |
| Ryan McSeveney | Bluejay Diagnostics | N/A | |
| Nicholas DeGennaro | Vivos Therapeutics | N/A | |
| Susan RN | NeuroMetrix | N/A | |
| Shmuel Gov | STRATA Skin Sciences | 64 | |
| Eryn Graham | Bluejay Diagnostics | N/A | |
| Lindsey Harrison | NanoVibronix | N/A | |
| Meshira Greenberg | Inspira Technologies Oxy | N/A | |
| Leah Akin | Neuropace | N/A | |
| Andrew Cormack | enVVeno Medical Corp | N/A | |
| Irene Thomas | Neuropace | 55 | |
| Stephen CPA | NanoVibronix | 68 | |
| Michael Soule | Movano Inc | N/A | |
| Kimberly Bambach | Tivic Health Systems | 53 | |
| Irina Ridley | Neuropace | 38 | |
| Sandy Prietto | enVVeno Medical Corp | N/A | |
| Les DeLuca | Bluejay Diagnostics | N/A | |
Management Performance
| Return On Equity | -3.15 | ||||
| Return On Asset | -0.52 |
OpGen Inc Leadership Team
Elected by the shareholders, the OpGen's board of directors comprises two types of representatives: OpGen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OpGen. The board's role is to monitor OpGen's management team and ensure that shareholders' interests are well served. OpGen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OpGen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Albert Weber, CFO Secretary | ||
| Michael Farmer, VP Marketing | ||
| Honjian Tan, CEO Chairman | ||
| Arne Materna, MD GmbH | ||
| Terrance Walker, Sr. VP of RandD | ||
| Derek Joesting, VP Sales | ||
| Vadim Sapiro, Chief Officer | ||
| Faranak Atrzadeh, Chief Officer | ||
| Theo deVos, MD Genetics | ||
| David Lazar, CEO Chairman | ||
| Johannes Bacher, Chief Officer | ||
| Oliver Schacht, Executive Development |
OpGen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is OpGen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.15 | ||||
| Return On Asset | -0.52 | ||||
| Operating Margin | (10.13) % | ||||
| Current Valuation | 29.68 M | ||||
| Shares Outstanding | 8.36 M | ||||
| Shares Owned By Insiders | 3.63 % | ||||
| Shares Owned By Institutions | 0.26 % | ||||
| Number Of Shares Shorted | 13.44 K | ||||
| Price To Earning | (0.39) X | ||||
| Price To Book | 2.79 X |
Pair Trading with OpGen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OpGen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OpGen will appreciate offsetting losses from the drop in the long position's value.Moving against OpGen Pink Sheet
| 0.65 | MYO | Myomo Inc | PairCorr |
| 0.53 | GMED | Globus Medical | PairCorr |
| 0.5 | VMSI | Vita Mobile Systems | PairCorr |
| 0.47 | NXL | Nexalin Technology | PairCorr |
| 0.43 | HDII | Hypertension Diagnostics | PairCorr |
The ability to find closely correlated positions to OpGen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OpGen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OpGen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OpGen Inc to buy it.
The correlation of OpGen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OpGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OpGen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OpGen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in OpGen Pink Sheet
If you are still planning to invest in OpGen Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OpGen's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |